Civica Rx and Exela Pharma Sciences have inked a long-term agreement to manufacture and supply Civica’s growing membership of U.S. health systems with sodium bicarbonate injection, which has been in critically short supply in U.S. hospitals.   Exela, founded in 2005, recently received approval from the U.S. Food and Drug Administration (FDA) to manufacture sodium bicarbonate, which is used for emergency care in hospitals to treat metabolic acidosis which may be due to severe kidney disease...